Physician profile
Michael Lott
NPI 1316122922
$9,262.80
in general payments reported to CMS, 2019-2025
43 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 75% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,421 · 2020: $662 · 2021: $989 · 2022: $874 · 2023: $2,493 · 2024: $1,186 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,097 · Travel and Lodging: $1,040 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,097.18 |
| Travel and Lodging | $1,040.05 |
| Education | $180.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,657.91 | 2021-2025 | Proclaim, Octrode, Eterna |
| Relievant Medsystems, INC. | $1,007.52 | 2023 | Intracept |
| Boston Scientific Corporation | $882.95 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $870.79 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Scilex Pharmaceuticals INC. | $665.31 | 2019-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $622.49 | 2019-2025 | Relistor |
| Nevro Corp. | $429.40 | 2019-2024 | Senza |
| Horizon Therapeutics Plc | $304.77 | 2019-2022 | |
| Medtronic USA, INC. | $238.92 | 2019-2020 | |
| Painteq LLC | $225.92 | 2022-2024 | Painteq |
| Vertiflex, INC. | $212.91 | 2019 | |
| Azurity Pharmaceuticals, INC. | $212.37 | 2023-2025 | Horizant, Horizant |
| Medtronic, INC. | $198.54 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Vertos Medical, INC. | $144.15 | 2024 | Mild Device Kit |
| Biotronik Nro, INC. | $140.02 | 2025 | Prospera |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.